Does COVID-19 increase the risk of neuropsychiatric sequelae? Evidence from a mendelian randomization approach

doi:10.5498/wjp.v12.i3.536

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4858)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

286

WORD

HTML

2803

Figures (1-1)

150

Tables (1-1)

133

Sum=3470

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

194

Download

383

Sum=577

Publishing Process of This Article

Item

Count

Browse

321

Download

490

Sum=811

Mar 19, 2022 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Psychiatry. Mar 19, 2022; 12(3): 536-540
Published online Mar 19, 2022. doi: 10.5498/wjp.v12.i3.536

Open in New Tab Full Size Figure Download Figure

Figure 1 Mendelian randomization analysis testing (A) severe, (B) hospitalized and (C) all Covid-19 forms against the risk of neuropsychiatric/neurological disorders. Odds ratios with 95% confidence intervals and P value from Mendelian randomization analyses are reported for each disorder tested as outcome against the three forms of coronavirus disease 2019 tested as exposure, with the number of instrumental variants (#IVs) analyzed. MR: Mendelian randomization; AD: Alzheimer’s disease; GAD: Generalized anxiety disorder; OR: Odds ratios; CI: Confidence interval; NA: Not available. *Not available on MR-Base (see Data Availability statement or [5] for details).

Citation: Tirozzi A, Santonastaso F, de Gaetano G, Iacoviello L, Gialluisi A. Does COVID-19 increase the risk of neuropsychiatric sequelae? Evidence from a mendelian randomization approach. World J Psychiatry 2022; 12(3): 536-540
URL: https://www.wjgnet.com/2220-3206/full/v12/i3/536.htm
DOI: https://dx.doi.org/10.5498/wjp.v12.i3.536